An open‐label study to explore the optimal design of CYP3A drug–drug interaction clinical trials in healthy Chinese people.

Autor: Chen, Jingcheng1, Li, Jiangshuo1, Wu, Jingxuan1, Song, Yuqin1, Li, Lijun1, Zhang, Jianxiong1, Dong, Ruihua1 rui_hua_dong_rw@163.com
Zdroj: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-9. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje